In the study conducted by Ulukaya et al., assessment of changes in the cleaved subunit of cytokeratin 18 during neoadjuvant chemotherapy in breast cancer patients showed significantly increased serum levels 24 hours after the initiation of treatment (22). The gene discussed is KRT18; the disease is breast carcinoma.